Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles

S. Andreasen, Q. Tan, TK. Agander, P. Steiner, K. Bjørndal, E. Høgdall, SR. Larsen, D. Erentaite, CH. Olsen, BP. Ulhøi, SL. von Holstein, I. Wessel, S. Heegaard, P. Homøe,

. 2018 ; 31 (8) : 1211-1225. [pub] 20180221

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028558

Adenoid cystic carcinoma is among the most frequent malignancies in the salivary and lacrimal glands and has a grave prognosis characterized by frequent local recurrences, distant metastases, and tumor-related mortality. Conversely, adenoid cystic carcinoma of the breast is a rare type of triple-negative (estrogen and progesterone receptor, HER2) and basal-like carcinoma, which in contrast to other triple-negative and basal-like breast carcinomas has a very favorable prognosis. Irrespective of site, adenoid cystic carcinoma is characterized by gene fusions involving MYB, MYBL1, and NFIB, and the reason for the different clinical outcomes is unknown. In order to identify the molecular mechanisms underlying the discrepancy in clinical outcome, we characterized the phenotypic profiles, pattern of gene rearrangements, and global microRNA expression profiles of 64 salivary gland, 9 lacrimal gland, and 11 breast adenoid cystic carcinomas. All breast and lacrimal gland adenoid cystic carcinomas had triple-negative and basal-like phenotypes, while salivary gland tumors were indeterminate in 13% of cases. Aberrations in MYB and/or NFIB were found in the majority of cases in all three locations, whereas MYBL1 involvement was restricted to tumors in the salivary gland. Global microRNA expression profiling separated salivary and lacrimal gland adenoid cystic carcinoma from their respective normal glands but could not distinguish normal breast adenoid cystic carcinoma from normal breast tissue. Hierarchical clustering separated adenoid cystic carcinomas of salivary gland origin from those of the breast and placed lacrimal gland carcinomas in between these. Functional annotation of the microRNAs differentially expressed between salivary gland and breast adenoid cystic carcinoma showed these as regulating genes involved in metabolism, signal transduction, and genes involved in other cancers. In conclusion, microRNA dysregulation is the first class of molecules separating adenoid cystic carcinoma according to the site of origin. This highlights a novel venue for exploring the biology of adenoid cystic carcinoma.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028558
003      
CZ-PrNML
005      
20190823102255.0
007      
ta
008      
190813s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41379-018-0005-y $2 doi
035    __
$a (PubMed)29467480
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Andreasen, Simon $u Department of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Køge, Denmark. Simon@Andreasen.pm. Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen, Denmark. Simon@Andreasen.pm.
245    10
$a Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles / $c S. Andreasen, Q. Tan, TK. Agander, P. Steiner, K. Bjørndal, E. Høgdall, SR. Larsen, D. Erentaite, CH. Olsen, BP. Ulhøi, SL. von Holstein, I. Wessel, S. Heegaard, P. Homøe,
520    9_
$a Adenoid cystic carcinoma is among the most frequent malignancies in the salivary and lacrimal glands and has a grave prognosis characterized by frequent local recurrences, distant metastases, and tumor-related mortality. Conversely, adenoid cystic carcinoma of the breast is a rare type of triple-negative (estrogen and progesterone receptor, HER2) and basal-like carcinoma, which in contrast to other triple-negative and basal-like breast carcinomas has a very favorable prognosis. Irrespective of site, adenoid cystic carcinoma is characterized by gene fusions involving MYB, MYBL1, and NFIB, and the reason for the different clinical outcomes is unknown. In order to identify the molecular mechanisms underlying the discrepancy in clinical outcome, we characterized the phenotypic profiles, pattern of gene rearrangements, and global microRNA expression profiles of 64 salivary gland, 9 lacrimal gland, and 11 breast adenoid cystic carcinomas. All breast and lacrimal gland adenoid cystic carcinomas had triple-negative and basal-like phenotypes, while salivary gland tumors were indeterminate in 13% of cases. Aberrations in MYB and/or NFIB were found in the majority of cases in all three locations, whereas MYBL1 involvement was restricted to tumors in the salivary gland. Global microRNA expression profiling separated salivary and lacrimal gland adenoid cystic carcinoma from their respective normal glands but could not distinguish normal breast adenoid cystic carcinoma from normal breast tissue. Hierarchical clustering separated adenoid cystic carcinomas of salivary gland origin from those of the breast and placed lacrimal gland carcinomas in between these. Functional annotation of the microRNAs differentially expressed between salivary gland and breast adenoid cystic carcinoma showed these as regulating genes involved in metabolism, signal transduction, and genes involved in other cancers. In conclusion, microRNA dysregulation is the first class of molecules separating adenoid cystic carcinoma according to the site of origin. This highlights a novel venue for exploring the biology of adenoid cystic carcinoma.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a adenoidně cystický karcinom $x genetika $x patologie $7 D003528
650    _2
$a nádory oka $x genetika $x patologie $7 D005134
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a nemoci slzného ústrojí $x genetika $x patologie $7 D007766
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikro RNA $x analýza $7 D035683
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádory slinných žláz $x genetika $x patologie $7 D012468
650    _2
$a triple-negativní karcinom prsu $x genetika $x patologie $7 D064726
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Tan, Qihua $u Department of Clinical Research, Unit of Human Genetics, University of Southern Denmark, Odense, Denmark.
700    1_
$a Agander, Tina Klitmøller $u Department of Pathology, Rigshospitalet, Copenhagen, Denmark.
700    1_
$a Steiner, Petr $u Department of Pathology, Faculty of Medicine, Charles University in Prague, Pilsen, Czech Republic. Bioptic Laboratory Ltd, Molecular Pathology Laboratory, Pilsen, Czech Republic.
700    1_
$a Bjørndal, Kristine $u Department of ORL-Head and Neck Surgery, Odense University Hospital, Odense, Denmark.
700    1_
$a Høgdall, Estrid $u Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.
700    1_
$a Larsen, Stine Rosenkilde $u Department of Pathology, Odense University Hospital, Odense, Denmark.
700    1_
$a Erentaite, Daiva $u Department of Pathology, Aalborg University Hospital, Aalborg, Denmark.
700    1_
$a Olsen, Caroline Holkmann $u Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
700    1_
$a Ulhøi, Benedicte Parm $u Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
700    1_
$a von Holstein, Sarah Linéa $u Department of Ophthalmology, Rigshospitalet-Glostrup, Copenhagen, Denmark. Department of Ophthalmology, Zealand University Hospital, Roskilde, Denmark.
700    1_
$a Wessel, Irene $u Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen, Denmark.
700    1_
$a Heegaard, Steffen $u Department of Pathology, Rigshospitalet, Copenhagen, Denmark. Department of Ophthalmology, Rigshospitalet-Glostrup, Copenhagen, Denmark.
700    1_
$a Homøe, Preben $u Department of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Køge, Denmark.
773    0_
$w MED00003380 $t Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc $x 1530-0285 $g Roč. 31, č. 8 (2018), s. 1211-1225
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29467480 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190823102509 $b ABA008
999    __
$a ok $b bmc $g 1433707 $s 1067018
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 31 $c 8 $d 1211-1225 $e 20180221 $i 1530-0285 $m Modern pathology $n Mod Pathol $x MED00003380
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace